Medicare Enrolled
Dr. Oleg Gligich, M.D
Internal Medicine · Miami Beach, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Gligich from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gligich?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Gligich
Dr. Oleg Gligich is an internal medicine specialist in Miami Beach, FL, with 15 years of NPI registration. Based on federal Medicare data, Dr. Gligich performed 942 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Gligich received a total of $34,256 from 83 pharmaceutical and/or device companies across 1222 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Gligich is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years of NPI registration
▲ Top 41% volume in FL
$34,256 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 131522 | Clear | January 31, 2027 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗942
Medicare services
Top 41% in FL for internal medicine
Not available
Unique patients (not deduplicated)
$83
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
766 | $79 | $252 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
66 | $52 | $165 |
| New patient office visit, complex (60-74 min) | 64 | $154 | $552 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
24 | $69 | $228 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $114 | $449 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$34,256
Total received (2018-2024)
Avg $4,894/year across 7 years
Top 2% in FL for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
83
Companies
1,222
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$6,520
2023
$8,052
2022
$6,349
2021
$6,741
2020
$4,483
2019
$1,317
2018
$795
Payments by company (2024)
BeiGene USA, Inc.
$2,030
Celgene Corporation
$521
Novartis Pharmaceuticals Corporation
$461
Daiichi Sankyo Inc.
$451
Janssen Biotech, Inc.
$325
PFIZER INC.
$321
Tempus AI, Inc
$314
Sumitomo Pharma America, Inc.
$209
Merck Sharp & Dohme LLC
$153
ABBVIE INC.
$140
Mirati Therapeutics, Inc.
$108
SpringWorks Therapeutics, Inc.
$106
E.R. Squibb & Sons, L.L.C.
$103
ARRAY BIOPHARMA INC
$90
Astellas Pharma US Inc
$82
TAIHO ONCOLOGY, INC.
$82
Genentech USA, Inc.
$81
AstraZeneca Pharmaceuticals LP
$74
Alexion Pharmaceuticals, Inc.
$69
EMD Serono, Inc.
$66
GENZYME CORPORATION
$66
Gilead Sciences, Inc.
$65
Bayer Healthcare Pharmaceuticals Inc.
$60
Adaptive Biotechnologies Corporation
$56
Incyte Corporation
$46
GlaxoSmithKline, LLC.
$44
Regeneron Healthcare Solutions, Inc.
$38
Exelixis Inc.
$38
JAZZ PHARMACEUTICALS INC.
$33
Rigel Pharmaceuticals, Inc.
$33
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Stemline Therapeutics Inc.
$30
Kite Pharma, Inc.
$28
Genmab U.S., Inc.
$25
Aveo Pharmaceuticals, Inc.
$24
MorphoSys, US Inc.
$24
SERVIER PHARMACEUTICALS LLC
$23
Myriad Genetic Laboratories, Inc.
$20
Eisai Inc.
$19
Takeda Pharmaceuticals U.S.A., Inc.
$17
Blueprint Medicines Corporation
$14
Top 3 companies account for 46.2% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$3,467
BeiGene USA, Inc.
$2,202
Daiichi Sankyo Inc.
$2,091
E.R. Squibb & Sons, L.L.C.
$1,969
Celgene Corporation
$1,877
NOVARTIS PHARMACEUTICALS CORPORATION
$1,838
Janssen Biotech, Inc.
$1,611
Karyopharm Therapeutics Inc.
$1,570
Novartis Pharmaceuticals Corporation
$1,305
PFIZER INC.
$1,157
Genentech USA, Inc.
$1,100
Astellas Pharma US Inc
$1,010
Amgen Inc.
$863
Janssen Scientific Affairs, LLC
$829
Merck Sharp & Dohme Corporation
$785
Seagen Inc.
$659
GENZYME CORPORATION
$604
Incyte Corporation
$587
BeiGene, Ltd.
$525
Merck Sharp & Dohme LLC
$511
ABBVIE INC.
$333
Tempus AI, Inc
$314
EMD Serono, Inc.
$314
ARRAY BIOPHARMA INC
$312
Bayer HealthCare Pharmaceuticals Inc.
$308
Sumitomo Pharma America, Inc.
$281
Eisai Inc.
$264
Lilly USA, LLC
$249
GlaxoSmithKline, LLC.
$241
Pharmacyclics LLC, An AbbVie Company
$234
G1 Therapeutics, Inc.
$227
Epizyme, Inc.,
$222
Pharmacyclics LLC, an AbbVie Company
$207
Exelixis Inc.
$204
ADC Therapeutics America, Inc.
$181
EISAI INC.
$170
Sirtex Medical Inc
$165
Gilead Sciences, Inc.
$162
Mirati Therapeutics, Inc.
$143
Kite Pharma, Inc.
$140
Myovant Sciences Inc.
$134
Myriad Genetic Laboratories, Inc.
$132
Adaptive Biotechnologies Corporation
$132
Alexion Pharmaceuticals, Inc.
$132
SERVIER PHARMACEUTICALS LLC
$131
Janssen Pharmaceuticals, Inc
$128
AbbVie Inc.
$128
AVEO Pharmaceuticals, Inc.
$125
TAIHO ONCOLOGY, INC.
$122
MorphoSys, US Inc.
$112
SpringWorks Therapeutics, Inc.
$106
Foundation Medicine, Inc.
$100
Ipsen Biopharmaceuticals, Inc
$93
Genmab U.S., Inc.
$92
Bayer Healthcare Pharmaceuticals Inc.
$91
ImmunoGen, Inc.
$90
Deciphera Pharmaceuticals Inc.
$81
Kyowa Kirin, Inc.
$80
Boehringer Ingelheim Pharmaceuticals, Inc.
$80
Rigel Pharmaceuticals, Inc.
$77
Dova Pharmaceuticals
$65
Regeneron Healthcare Solutions, Inc.
$62
CTI BioPharma Corp.
$53
Takeda Pharmaceuticals U.S.A., Inc.
$52
Clovis Oncology, Inc.
$51
Acceleron Pharma, Inc.
$50
Partner Therapeutics, Inc.
$49
Stemline Therapeutics Inc.
$47
JAZZ PHARMACEUTICALS INC.
$46
SANOFI-AVENTIS U.S. LLC
$45
Apellis Pharmaceuticals, Inc.
$40
Taiho Oncology, Inc.
$34
Blueprint Medicines Corporation
$32
Sun Pharmaceutical Industries Inc.
$32
RefleXion Medical, Inc.
$30
MEDIVATION FIELD SOLUTIONS LLC
$29
Pharmacosmos Therapeutics Inc.
$25
Epizyme, Inc.
$25
Aveo Pharmaceuticals, Inc.
$24
AbbVie, Inc.
$21
Advanced Accelerator Applications
$20
BIOVERATIV THERAPEUTICS INC.
$15
AMAG Pharmaceuticals, Inc.
$15
Top 3 companies account for 22.7% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AKEEGA · ALIMTA · ALPROLIX · AYVAKIT · Alecensa · Avastin · BAVENCIO · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · CABLIVI · CABOMETYX · CALQUENCE · CARVYKTI · COSELA · CYRAMZA · Cabometyx · Columvi · DARZALEX · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMEND · ENHERTU · ENJAYMO · EPKINLY · ERLEADA · Elahere · Empaveli · Enhertu · Epkinly · FERAHEME · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE CDX · FRUZAQLA · Fabhalta · GAZYVA · GILOTRIF · Halaven · IBRANCE · ICLUSIG · IDHIFA · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INQOVI · INREBIC · Idhifa · Imbruvica · JAKAFI · JEMPERLI · KANJINTI · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LEUKINE · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Leukine · Lunsumio · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · MYRISK · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · ONUREG · OPDIVO · ORGOVYX · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PROSTATE CANCER - DISEASE · Padcev · Perjeta · Phesgo · Pomalyst · QINLOCK · REBLOZYL · REFLEXION MEDICAL RADIOTHERAPY SYSTEM · RETEVMO · RYBREVANT · Reblozyl · Revlimid · Rezlidhia · Rubraca · SANDOSTATIN · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOLIRIS · SOMATULINE DEPOT · SUTENT · Stivarga · TABRECTA · TAGRISSO · TASIGNA · TAZVERIK · TECENTRIQ · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tazverik · Tecentriq · Tibsovo · Trodelvy · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · Venclexta · Vitrakvi · Vonjo · XALKORI · XARELTO · XGEVA · XOSPATA · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ · myRisk
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Internal medicine physicians in nearby ZIP areas
2,083
County median income
$68,694
Nearest hospital to ZIP centroid (approximate)
MOUNT SINAI MEDICAL CENTER OF FLORIDA, INC
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Gligich is a clinical cardiology specialist, with moderate Medicare volume, with 15 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Gligich experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Gligich performed 766 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Gligich receive payments from pharmaceutical companies?
Yes. Dr. Gligich received a total of $34,256 from 83 companies across 1,222 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gligich's costs compare to other internal medicine physicians in Miami Beach?
Dr. Gligich's average Medicare payment per service is $83. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gligich) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in Miami Beach
Browse internal medicine physicians in Miami Beach ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in FL
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in FL
Which FL internal medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc.
By company
Daiichi Sankyo Inc. Payments to Doctors
See all physicians who received payments from Daiichi Sankyo Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology